Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-107 manufacturers

Filters

None products found

pp-107

Tablets

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
Comments
Indication: Progressive supranuclear palsy (PSP), a rare, rapidly progressing tau‑associated neurodegenerative disorder in adults Clinical stage: Phase 2 clinical development with topline recruitment completed Modality: Small molecule Mechanism / Target: Selective O‑GlcNAcase (OGA) enzyme inhibition to increase tau O‑GlcNAcylation and potentially reduce pathological tau aggregation Route / form: Oral administration (tablet) Differentiation: Brain‑penetrant OGA inhibitor targeting tau pathology with potential disease‑modifying effects in PSP where no approved therapies exist
Manufacturer #12186
The activity of the company is based on the development of highly competitive processes for the manufacture of active ingredients with high added value that meet the strictest quality specifications. They manufacture under strict compliance with the environmental and occupational safety regulations in force in Europe. They focus on the pharmaceutical, hospital, diagnostic, fine chemical, and food fields. Its products are marketed in more than 70 countries.

Manufacturer usually replies in 2 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.